| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/03/1991 | US5045469 Novel bacillus thuringiensis isolate denoted B. T. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 09/03/1991 | US5045462 Basic protein called phospholipase A2 isolated from the venom of a snake of the family elapidae and its amino acid sequence |
| 09/03/1991 | US5045455 DNA sequences, genetic engineering, blood coagulants, hemophilia |
| 09/03/1991 | US5045312 Complexing |
| 09/03/1991 | CA2077446A1 Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same |
| 09/03/1991 | CA2077348A1 Antibody constructs with enhanced binding affinity |
| 09/03/1991 | CA2077345A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 09/03/1991 | CA2077340A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens |
| 09/03/1991 | CA2077338A1 Hybrid compound purification |
| 09/03/1991 | CA2054725A1 Ptpase vectors, diagnostics, therapeutics and uses thereof |
| 09/03/1991 | CA2037452A1 Use of interleukin-1 to enhance the immune response of weakly immunogenic tumors |
| 09/03/1991 | CA2037440A1 Her3: a novel egf receptor homolog |
| 09/03/1991 | CA1288351C Angiotensin converting enzyme inhibitors useful in prolonging survivalof mammalians with congestive heart failure |
| 09/03/1991 | CA1288341C2 Physiologically active compositions |
| 09/03/1991 | CA1288340C Interleukin-2 composition |
| 09/02/1991 | CA2037325A1 Thrombin composition for oral administration |
| 08/29/1991 | WO1991013088A1 Terminally blocked antiviral peptides |
| 08/29/1991 | WO1991013081A1 Physiologically active substance well capable of permeating biomembrane |
| 08/29/1991 | DE4104787A1 New bi:specific monoclonal antibody recognising human TNF - and horseradish peroxidase, and hybridoma producing it, useful in simplified assay of TNF |
| 08/29/1991 | DE4104308A1 Therapeutische verwendung von somatostatinpeptiden Therapeutic use of somatostatinpeptiden |
| 08/29/1991 | DE4006269A1 Antibody which binds to tumour necrosis factor receptors |
| 08/29/1991 | DE4006141A1 Decaplanin salt solns. used for injection |
| 08/29/1991 | CA2077088A1 Terminally blocked antiviral peptides |
| 08/29/1991 | CA2076849A1 Physiologically active substance well capable of permeating biomembrane |
| 08/29/1991 | CA2037199A1 Inhibitors of catalytic antibodies |
| 08/28/1991 | WO1991013152A1 SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-β1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN |
| 08/28/1991 | EP0443891A1 Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation |
| 08/28/1991 | EP0443875A2 Vectors and compounds for expression of zymogen forms of human protein C |
| 08/28/1991 | EP0443874A2 Vectors and compounds for expression of glycosylation mutants of human protein C |
| 08/28/1991 | EP0443790A1 Growth hormone-like glycoproteins |
| 08/28/1991 | EP0443724A1 Viral-safe purified human thrombin |
| 08/28/1991 | EP0443719A1 Novel R106 compounds |
| 08/28/1991 | EP0443599A2 Monoclonal antibodies specific for tumor-associated antigens, method for their preparation and their use |
| 08/28/1991 | EP0443598A2 Peptides inhibiting the blood coagulation, their process of preparation and their use |
| 08/28/1991 | EP0443573A2 HIV protease inhibitors containing derived amino acids |
| 08/28/1991 | EP0443560A2 HIV protease inhibitors |
| 08/28/1991 | EP0443559A2 HIV protease inhibiting agents |
| 08/28/1991 | EP0443429A1 Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin |
| 08/28/1991 | EP0443404A1 Peptide fragments and analogs of thrombospondin |
| 08/28/1991 | EP0443335A1 Recombinant pox virus plasmid containing a multi-functional DNA cassette |
| 08/28/1991 | EP0443224A1 Use of thrombospondin to promote wound healing |
| 08/28/1991 | EP0443132A1 Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same |
| 08/28/1991 | EP0443094A2 Non-biodegradable, two-phase corneal implant and method for preparing same |
| 08/28/1991 | EP0443047A1 Liquid nutrient composition |
| 08/28/1991 | EP0442926A1 Polypeptides |
| 08/28/1991 | EP0267208B1 An insulin preparation for non-parenteral administration |
| 08/28/1991 | EP0164403B1 Feline leukemia virus vaccine |
| 08/28/1991 | EP0116571B1 Method for making gamma globulin-containing compositions |
| 08/28/1991 | EP0109439B1 Amino acid solutions for parenteral nutrition and methods of formulation and use |
| 08/28/1991 | CN1054071A Orally active renin inhibitors |
| 08/28/1991 | CN1054009A Prolonged release microcapsules |
| 08/28/1991 | CA2036963A1 Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| 08/27/1991 | WO1991013089A1 Peptide derivatives and production thereof |
| 08/27/1991 | US5043431 Method and apparatus for the production of TGF-β |
| 08/27/1991 | US5043429 Anticoagulant polypeptide |
| 08/27/1991 | US5043428 Using carbohydrate anion exchange resin, eluting with calcium ons |
| 08/27/1991 | US5043425 Anticoagulants |
| 08/27/1991 | US5043422 Polypeptide; prevention, therapy aids |
| 08/27/1991 | US5043346 Amino acid esters, pharmaceuticals containing them, and the use thereof in learning disorders |
| 08/27/1991 | US5043323 Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them |
| 08/27/1991 | US5043322 Cyclic GRF analogs |
| 08/27/1991 | US5043321 Adrenocorticotropin release inhibiting factor |
| 08/27/1991 | US5043281 Human monoclonal antibodies against cytomegalovirus and process for producing same |
| 08/27/1991 | US5043158 Immunogenic compositions containing ordered carriers |
| 08/27/1991 | US5043156 Method of treating infectious diseases with granulocyte colony-stimulating factor |
| 08/27/1991 | US5043101 Forming metal-transferrin and metal-dextran compounds, combining to form metal-transferrin-dextran |
| 08/27/1991 | CA2053895A1 Peptide derivatives and production thereof |
| 08/27/1991 | CA1288196C Process for production of dry bioactive recombinant growth hormones |
| 08/27/1991 | CA1288195C Gnrh antagonists ix |
| 08/24/1991 | WO1991012815A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO β-LACTAM ANTIBIOTICS |
| 08/24/1991 | CA2076529A1 Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
| 08/24/1991 | CA2036915A1 Vectors and compounds for expression of zymogen forms of human protein c |
| 08/23/1991 | WO1991012784A1 Neuropeptide control of ocular growth |
| 08/23/1991 | CA2036815A1 Peptides which inhibit blood coagulation, processes for the preparation thereof and the use thereof |
| 08/23/1991 | CA2036093A1 Peptide fragments and analogs of thrombospondin |
| 08/22/1991 | WO1991012817A1 Novel insulin compositions |
| 08/22/1991 | WO1991012334A1 Inhibitor of cytokine activity and applications thereof |
| 08/22/1991 | WO1991012330A1 Production of immunosuppressive factor |
| 08/22/1991 | WO1991012324A1 Novel human cyclin a compositions and their production method, a corresponding nucleotide sequence, a method and agents for detecting or diagnosing cell multiplication, and a method and agents for inhibiting cell multiplication |
| 08/22/1991 | WO1991012320A1 Activated protein c with truncated light chain |
| 08/22/1991 | WO1991012316A1 Method for preparing blood derivatives and derivatives thereby obtained |
| 08/22/1991 | WO1991012274A1 Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use |
| 08/22/1991 | WO1991012272A1 Protein factor |
| 08/22/1991 | WO1991012271A1 Synthetic peptides for neutralizing the infectivity of the aids virus (hiv) |
| 08/22/1991 | WO1991012270A2 Novel platelet aggregation inhibitors from the leech |
| 08/22/1991 | WO1991012266A1 Peptide compound |
| 08/22/1991 | WO1991012263A1 Symmetrical bipeptides including a polyalkylene-gylcol group, method of preparation and use in protease determination |
| 08/22/1991 | WO1991012262A1 Glutathione derivative |
| 08/22/1991 | WO1991012023A2 Hybrid reagents capable of selectively releasing molecules into cells |
| 08/22/1991 | WO1991012018A1 Method for treating intestinal diseases |
| 08/22/1991 | WO1991012016A1 Administration of peptides in ovo |
| 08/22/1991 | WO1991012015A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell |
| 08/22/1991 | WO1991012014A1 A growth factor in connection with artificial transplants |
| 08/22/1991 | WO1991010736A3 CLONING AND CHARACTERIZATION OF THE CD3θ SUBUNIT |
| 08/22/1991 | WO1991009951A3 Recombinant protein c with truncated light chain |
| 08/22/1991 | DE4005062A1 Mammary-derived Growth Inhibitor peptide(s) - and antibodies useful in bio technology and medicine as proliferation inhibitors e.g. of carcinoma cells |
| 08/22/1991 | DE4004898A1 New peptide renin inhibitors - useful for treatment of coronary, circulation and vascular disorders, and to treat diseases due to retroviral infections |
| 08/22/1991 | DE4003944A1 New synthetic polypeptide conjugate of LHRH and keyhole limpet haemocy - used to provide antibodies to hormone, for treating breast and prostate carcinoma etc. |
| 08/22/1991 | CA2075982A1 Insulin compositions |
| 08/22/1991 | CA2050929A1 Glutathione derivatives |